France backs COVID-19 vaccine IP waiver
French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.
Brands urged to ‘cast a wide net’ for cannabis TMs: WIPR TM Live
Companies looking to enter the booming cannabis industry should “cast a wider net” when registering trademarks, according to a virtual panel discussion.
(WATCH) Lisa Ferri of Mayer Brown on the COVID-19 waiver
Talks over a COVID-19 vaccine waiver ended this week at the World Trade Organization in Geneva, with an agreement to work towards a text-based response to the plan.
Oakwood convinces third circuit to reopen TS suit
Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.
EU backs compulsory licensing for COVID vaccines
The European Union has submitted a new proposal to the World Trade Organisation, which backs compulsory licensing agreements for COVID-19 vaccines when negotiations fail.
Endo, Impax face class-action over antitrust claims
Endo International and Amneal Pharmaceuticals’ subsidiary, Impax Laboratories, have failed to prevent antitrust claims over a patent settlement from going to trial.
Cannabis company to face ‘Kool’ menthol dilution claims
Cannabis company Capna has failed to convince a California district court judge to dismiss a trademark suit alleging it infringed a tobacco company’s cigarette marks.
Clarus succeeds in invalidating four Lipocine testosterone patents
Clarus Therapeutics has convinced a US court to invalidate four Lipocine testosterone booster patents it was accused of infringing.
AbbVie says bar for ‘sham litigation’ is too low
AbbVie has again urged the US Supreme Court to save it from claims of filing sham litigation to block competition for testosterone treatment AndroGel.
Federal Circuit upholds another ITC decision in 10X vs Bio-Rad
The US Court of Appeals for the Federal Circuit has upheld a decision from the US International Trade Commission that found 10X Genomics infringed on two Bio-Rad Laboratories gene sequencing patents.
